The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-l,2,4-benzotriazine-l ,4-dioxide (SR 4233, WIN 59075) by mouse liver (Q68232111)

From Wikidata

Jump to navigation Jump to search

scientific article published on July 22, 1992

Language	Label	Description	Also known as
English	The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-l,2,4-benzotriazine-l ,4-dioxide (SR 4233, WIN 59075) by mouse liver	scientific article published on July 22, 1992

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1642640%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233, WIN 59075) by mouse liver (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1642640%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-l,2,4-benzotriazine-l ,4-dioxide (SR 4233, WIN 59075) by mouse liver (English)

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

1 reference

based on heuristic

inferred from title

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

author name string

M. I. Walton

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642640

20 October 2022

C. R. Wolf

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642640

20 October 2022

P. Workman

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642640

20 October 2022

language of work or name

0 references

publication date

1 July 1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1642640%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

22 July 1992

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1642640

20 October 2022

full work available at URL

https://api.elsevier.com/content/article/PII:0006295292900076?httpAccept=text/xml

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

https://api.elsevier.com/content/article/PII:0006295292900076?httpAccept=text/plain

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1642640%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

44

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1642640%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1642640%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

251-259

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1642640%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells

1

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Enhancement of radiation-induced tumor cell killing by the hypoxic cell toxin SR 4233

2

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Structure-activity relationships for benzotriazine di-N-oxides

3

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

New drugs and novel agents

4

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneity

5

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Molecular mechanisms for the hypoxia-dependent activation of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233)

8

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical

9

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Molecular enzymology of the reductive bioactivation of hypoxic cell cytotoxins

11

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Enzymology of the reductive bioactivation of SR 4233. A novel benzotriazine di-N-oxide hypoxic cell cytotoxin

13

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Identification of two major reduction products of the hypoxic cell toxin 3-amino-1,2,4-benzotriazine-1,4-dioxide

14

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Reductive metabolism of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) and the induction of unscheduled DNA synthesis in rat and human derived cell lines

15

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Reductive drug metabolism.

16

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Metabolism and reactions of quinoid anticancer agents

17

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

The metabolic activation of nitroheterocyclic therapeutic agents

18

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

The rabbit pulmonary monooxygenase system: Characteristics and activities of two forms of pulmonary cytochrome P-450

22

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Isolation of a high spin form of cytochrome P-450 induced in rat liver by 3-methylcholanthrene

23

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Immunological comparison of rat, rabbit, and human liver NADPH-cytochrome P-450 reductases

24

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Protein measurement with the Folin phenol reagent

27

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Nitroimidazole bioreductive metabolism. Quantitation and characterisation of mouse tissue benznidazole nitroreductases in vivo and in vitro

28

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

High-performance liquid chromatographic assay for the benzotriazine di-N-oxide (SR 4233) and its reduced metabolites in biological materials

29

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Inhibitors of Cytochrome P-450s and their mechanism of action

30

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Reduction of tertiary amine N-oxides by liver microsomal cytochrome P-450

31

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Evidence for the involvement of cytochrome P-450 in tiaramide N-oxide reduction

32

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Reduced nicotinamide adenine dinucleotide-dependent reduction of tertiary amine N-oxide by liver microsomal cytochrome P-450

34

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

The anaerobic dechlorination of trichlorofluoro-methane by rat liver preparations in vitro

35

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Regulation of phenobarbital-inducible cytochrome P-450s in rat and mouse liver following dexamethasone administration and hypophysectomy

38

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Enzymology of the reduction of the potent benzotriazine-di-n-oxide hypoxic cell cytotoxin SR 4233 (win 59075) by NAD(P)H: (Quinone acceptor) oxidoreductase (EC 1.6.99.2) purified from walker 256 rat tumour cells

39

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Pyridine nucleotide cofactor requirements of indicine N-oxide reduction by hepatic microsomal cytochrome P-450

40

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Induction of rat liver microsomal and nuclear cytochrome P-450 by dietary 2-acetylaminofluorene and butylated hydroxytoluene.

41

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Mode of Action of Quindoxin and Substituted Quinoxaline-di- N -Oxides on Escherichia coli

42

1 reference

10.1016/0006-2952(92)90007-6

https://api.crossref.org/works/10.1016/0006-2952(92)90007-6

20 October 2022

Identifiers

10.1016/0006-2952(92)90007-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1642640%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1642640%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68232111&oldid=1754747651"